ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Chickenpox (Varicella) Vaccine - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-11V8704
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Chickenpox Varicella Vaccine Market Insights and Forecast to 2028
BUY CHAPTERS

Chickenpox (Varicella) Vaccine - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-11V8704
Report
November 2023
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Sanofi Pasteur
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken

Chickenpox (Varicella) Vaccine - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Chickenpox (Varicella) Vaccine - Market

Chickenpox (Varicella) Vaccine - Market

The global Chickenpox (Varicella) Vaccine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Chickenpox (Varicella) Vaccine in various end use industries. The expanding demands from the Kids Injection and Adults Injection, are propelling Chickenpox (Varicella) Vaccine market. Monovalent Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Combination Vaccine segment is estimated at % CAGR for the next seven-year period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Chickenpox (Varicella) Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Chickenpox (Varicella) Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Chickenpox (Varicella) Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Chickenpox (Varicella) Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Chickenpox (Varicella) Vaccine covered in this report include Merck & Co., Sanofi Pasteur, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross and Biken, etc.
The global Chickenpox (Varicella) Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck & Co.
Sanofi Pasteur
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken

Scope of Chickenpox (Varicella) Vaccine - Market Report

Report Metric Details
Report Name Chickenpox (Varicella) Vaccine - Market
CAGR 5%
Global Chickenpox (Varicella) Vaccine market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Chickenpox (Varicella) Vaccine market, Segment by Type:
  • Monovalent Vaccine
  • Combination Vaccine
Global Chickenpox (Varicella) Vaccine market, by Application
  • Kids Injection
  • Adults Injection
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Chickenpox (Varicella) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Chickenpox (Varicella) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What are the Application segmentation covered in the Chickenpox (Varicella) Vaccine - Market report?

Ans: The Applications covered in the Chickenpox (Varicella) Vaccine - Market report are Kids Injection, Adults Injection

What are the Type segmentation covered in the Chickenpox (Varicella) Vaccine - Market report?

Ans: The Types covered in the Chickenpox (Varicella) Vaccine - Market report are Monovalent Vaccine, Combination Vaccine

1 Chickenpox (Varicella) Vaccine Market Overview
1.1 Chickenpox (Varicella) Vaccine Product Overview
1.2 Chickenpox (Varicella) Vaccine Market Segment by Type
1.2.1 Monovalent Vaccine
1.2.2 Combination Vaccine
1.3 Global Chickenpox (Varicella) Vaccine Market Size by Type
1.3.1 Global Chickenpox (Varicella) Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Chickenpox (Varicella) Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Chickenpox (Varicella) Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2018-2023)
2 Global Chickenpox (Varicella) Vaccine Market Competition by Company
2.1 Global Top Players by Chickenpox (Varicella) Vaccine Sales (2018-2023)
2.2 Global Top Players by Chickenpox (Varicella) Vaccine Revenue (2018-2023)
2.3 Global Top Players by Chickenpox (Varicella) Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Chickenpox (Varicella) Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Chickenpox (Varicella) Vaccine Market Competitive Situation and Trends
2.5.1 Chickenpox (Varicella) Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Chickenpox (Varicella) Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chickenpox (Varicella) Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Chickenpox (Varicella) Vaccine Market
2.8 Key Manufacturers Chickenpox (Varicella) Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Chickenpox (Varicella) Vaccine Status and Outlook by Region
3.1 Global Chickenpox (Varicella) Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Chickenpox (Varicella) Vaccine Historic Market Size by Region
3.2.1 Global Chickenpox (Varicella) Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Chickenpox (Varicella) Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Chickenpox (Varicella) Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Chickenpox (Varicella) Vaccine Forecasted Market Size by Region
3.3.1 Global Chickenpox (Varicella) Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Chickenpox (Varicella) Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Chickenpox (Varicella) Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Chickenpox (Varicella) Vaccine by Application
4.1 Chickenpox (Varicella) Vaccine Market Segment by Application
4.1.1 Kids Injection
4.1.2 Adults Injection
4.2 Global Chickenpox (Varicella) Vaccine Market Size by Application
4.2.1 Global Chickenpox (Varicella) Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Chickenpox (Varicella) Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Chickenpox (Varicella) Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2018-2023)
5 North America Chickenpox (Varicella) Vaccine by Country
5.1 North America Chickenpox (Varicella) Vaccine Historic Market Size by Country
5.1.1 North America Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Chickenpox (Varicella) Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Chickenpox (Varicella) Vaccine Sales in Value by Country (2018-2023)
5.2 North America Chickenpox (Varicella) Vaccine Forecasted Market Size by Country
5.2.1 North America Chickenpox (Varicella) Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Chickenpox (Varicella) Vaccine Sales in Value by Country (2024-2029)
6 Europe Chickenpox (Varicella) Vaccine by Country
6.1 Europe Chickenpox (Varicella) Vaccine Historic Market Size by Country
6.1.1 Europe Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Chickenpox (Varicella) Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Chickenpox (Varicella) Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Chickenpox (Varicella) Vaccine Forecasted Market Size by Country
6.2.1 Europe Chickenpox (Varicella) Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Chickenpox (Varicella) Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Chickenpox (Varicella) Vaccine by Region
7.1 Asia-Pacific Chickenpox (Varicella) Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Chickenpox (Varicella) Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Chickenpox (Varicella) Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Chickenpox (Varicella) Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Chickenpox (Varicella) Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Chickenpox (Varicella) Vaccine Sales in Value by Region (2024-2029)
8 Latin America Chickenpox (Varicella) Vaccine by Country
8.1 Latin America Chickenpox (Varicella) Vaccine Historic Market Size by Country
8.1.1 Latin America Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Chickenpox (Varicella) Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Chickenpox (Varicella) Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Chickenpox (Varicella) Vaccine Forecasted Market Size by Country
8.2.1 Latin America Chickenpox (Varicella) Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Chickenpox (Varicella) Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Chickenpox (Varicella) Vaccine by Country
9.1 Middle East and Africa Chickenpox (Varicella) Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Chickenpox (Varicella) Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Chickenpox (Varicella) Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Chickenpox (Varicella) Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Chickenpox (Varicella) Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Chickenpox (Varicella) Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck & Co.
10.1.1 Merck & Co. Company Information
10.1.2 Merck & Co. Introduction and Business Overview
10.1.3 Merck & Co. Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck & Co. Chickenpox (Varicella) Vaccine Products Offered
10.1.5 Merck & Co. Recent Development
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur Company Information
10.2.2 Sanofi Pasteur Introduction and Business Overview
10.2.3 Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Pasteur Chickenpox (Varicella) Vaccine Products Offered
10.2.5 Sanofi Pasteur Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GSK Chickenpox (Varicella) Vaccine Products Offered
10.3.5 GSK Recent Development
10.4 Shanghai Institute
10.4.1 Shanghai Institute Company Information
10.4.2 Shanghai Institute Introduction and Business Overview
10.4.3 Shanghai Institute Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Shanghai Institute Chickenpox (Varicella) Vaccine Products Offered
10.4.5 Shanghai Institute Recent Development
10.5 BCHT
10.5.1 BCHT Company Information
10.5.2 BCHT Introduction and Business Overview
10.5.3 BCHT Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 BCHT Chickenpox (Varicella) Vaccine Products Offered
10.5.5 BCHT Recent Development
10.6 Changsheng
10.6.1 Changsheng Company Information
10.6.2 Changsheng Introduction and Business Overview
10.6.3 Changsheng Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Changsheng Chickenpox (Varicella) Vaccine Products Offered
10.6.5 Changsheng Recent Development
10.7 Keygen
10.7.1 Keygen Company Information
10.7.2 Keygen Introduction and Business Overview
10.7.3 Keygen Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Keygen Chickenpox (Varicella) Vaccine Products Offered
10.7.5 Keygen Recent Development
10.8 Green Cross
10.8.1 Green Cross Company Information
10.8.2 Green Cross Introduction and Business Overview
10.8.3 Green Cross Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Green Cross Chickenpox (Varicella) Vaccine Products Offered
10.8.5 Green Cross Recent Development
10.9 Biken
10.9.1 Biken Company Information
10.9.2 Biken Introduction and Business Overview
10.9.3 Biken Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Biken Chickenpox (Varicella) Vaccine Products Offered
10.9.5 Biken Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Chickenpox (Varicella) Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Chickenpox (Varicella) Vaccine Industrial Chain Analysis
11.4 Chickenpox (Varicella) Vaccine Market Dynamics
11.4.1 Chickenpox (Varicella) Vaccine Industry Trends
11.4.2 Chickenpox (Varicella) Vaccine Market Drivers
11.4.3 Chickenpox (Varicella) Vaccine Market Challenges
11.4.4 Chickenpox (Varicella) Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Chickenpox (Varicella) Vaccine Distributors
12.3 Chickenpox (Varicella) Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Merck
Sanofi Pasteur
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
List of Tables
    Table 1. Major Company of Monovalent Vaccine
    Table 2. Major Company of Combination Vaccine
    Table 3. Global Chickenpox (Varicella) Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 4. Global Chickenpox (Varicella) Vaccine Sales by Type (2018-2023) & (K Doses)
    Table 5. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type (2018-2023)
    Table 6. Global Chickenpox (Varicella) Vaccine Sales by Type (2018-2023) & (US& Million)
    Table 7. Global Chickenpox (Varicella) Vaccine Market Share in Value by Type (2018-2023)
    Table 8. Global Chickenpox (Varicella) Vaccine Price by Type (2018-2023) & (USD/dose)
    Table 9. Global Chickenpox (Varicella) Vaccine Sales by Type (2024-2029) & (K Doses)
    Table 10. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type (2024-2029)
    Table 11. Global Chickenpox (Varicella) Vaccine Sales by Type (2024-2029) & (US$ Million)
    Table 12. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type (2024-2029)
    Table 13. Global Chickenpox (Varicella) Vaccine Price by Type (2024-2029) & (USD/dose)
    Table 14. North America Chickenpox (Varicella) Vaccine Sales by Type (2018-2023) & (K Doses)
    Table 15. North America Chickenpox (Varicella) Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 16. Europe Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2018-2023)
    Table 17. Europe Chickenpox (Varicella) Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 18. Asia-Pacific Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2018-2023)
    Table 19. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 20. Latin America Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2018-2023)
    Table 21. Latin America Chickenpox (Varicella) Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 22. Middle East and Africa Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2018-2023)
    Table 23. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Type (2018-2023) & (US$ Million)
    Table 24. Global Chickenpox (Varicella) Vaccine Sales by Company (2018-2023) & (K Doses)
    Table 25. Global Chickenpox (Varicella) Vaccine Sales Share by Company (2018-2023)
    Table 26. Global Chickenpox (Varicella) Vaccine Revenue by Company (2018-2023) & (US$ Million)
    Table 27. Global Chickenpox (Varicella) Vaccine Revenue Share by Company (2018-2023)
    Table 28. Global Market Chickenpox (Varicella) Vaccine Price by Company (2018-2023) & (USD/dose)
    Table 29. Global Chickenpox (Varicella) Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 30. Global Chickenpox (Varicella) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chickenpox (Varicella) Vaccine as of 2022)
    Table 32. Date of Key Manufacturers Enter into Chickenpox (Varicella) Vaccine Market
    Table 33. Key Manufacturers Chickenpox (Varicella) Vaccine Product Type
    Table 34. Mergers & Acquisitions, Expansion Plans
    Table 35. Global Chickenpox (Varicella) Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Global Chickenpox (Varicella) Vaccine Sales by Region (2018-2023) & (K Doses)
    Table 37. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Region (2018-2023)
    Table 38. Global Chickenpox (Varicella) Vaccine Sales by Region (2018-2023) & (US$ Million)
    Table 39. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Region (2018-2023)
    Table 40. Global Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2018-2023)
    Table 41. Global Chickenpox (Varicella) Vaccine Sales by Region (2024-2029) & (K Doses)
    Table 42. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Region (2024-2029)
    Table 43. Global Chickenpox (Varicella) Vaccine Sales by Region (2024-2029) & (US$ Million)
    Table 44. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Region (2024-2029)
    Table 45. Global Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2024-2029)
    Table 46. Global Chickenpox (Varicella) Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 47. Global Chickenpox (Varicella) Vaccine Sales by Application (2018-2023) & (K Doses)
    Table 48. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application (2018-2023)
    Table 49. Global Chickenpox (Varicella) Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 50. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application (2018-2023)
    Table 51. Global Chickenpox (Varicella) Vaccine Price by Application (2018-2023) & (USD/dose)
    Table 52. Global Chickenpox (Varicella) Vaccine Sales by Application (2024-2029) & (K Doses)
    Table 53. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application (2024-2029)
    Table 54. Global Chickenpox (Varicella) Vaccine Sales by Application (2024-2029) & (US$ Million)
    Table 55. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application (2024-2029)
    Table 56. Global Chickenpox (Varicella) Vaccine Price by Application (2024-2029) & (USD/dose)
    Table 57. North America Chickenpox (Varicella) Vaccine Sales by Application (2018-2023) (K Doses)
    Table 58. North America Chickenpox (Varicella) Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 59. Europe Chickenpox (Varicella) Vaccine Sales by Application (2018-2023) (K Doses)
    Table 60. Europe Chickenpox (Varicella) Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 61. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Application (2018-2023) (K Doses)
    Table 62. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 63. Latin America Chickenpox (Varicella) Vaccine Sales by Application (2018-2023) (K Doses)
    Table 64. Latin America Chickenpox (Varicella) Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 65. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Application (2018-2023) (K Doses)
    Table 66. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Application (2018-2023) & (US$ Million)
    Table 67. North America Chickenpox (Varicella) Vaccine Sales by Country (2018-2023) & (K Doses)
    Table 68. North America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 69. North America Chickenpox (Varicella) Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 70. North America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 71. North America Chickenpox (Varicella) Vaccine Sales by Country (2024-2029) & (K Doses)
    Table 72. North America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 73. North America Chickenpox (Varicella) Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 74. North America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 75. Europe Chickenpox (Varicella) Vaccine Sales by Country (2018-2023) & (K Doses)
    Table 76. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 77. Europe Chickenpox (Varicella) Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 78. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 79. Europe Chickenpox (Varicella) Vaccine Sales by Country (2024-2029) & (K Doses)
    Table 80. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 81. Europe Chickenpox (Varicella) Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 82. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 83. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Region (2018-2023) & (K Doses)
    Table 84. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Region (2018-2023)
    Table 85. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Region (2018-2023) & (US$ Million)
    Table 86. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Value by Region (2018-2023)
    Table 87. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Region (2024-2029) & (K Doses)
    Table 88. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Region (2024-2029)
    Table 89. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Region (2024-2029) & (US$ Million)
    Table 90. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Value by Region (2024-2029)
    Table 91. Latin America Chickenpox (Varicella) Vaccine Sales by Country (2018-2023) & (K Doses)
    Table 92. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 93. Latin America Chickenpox (Varicella) Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 94. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 95. Latin America Chickenpox (Varicella) Vaccine Sales by Country (2024-2029) & (K Doses)
    Table 96. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 97. Latin America Chickenpox (Varicella) Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 98. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 99. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2018-2023) & (K Doses)
    Table 100. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2018-2023)
    Table 101. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2018-2023) & (US$ Million)
    Table 102. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2018-2023)
    Table 103. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2024-2029) & (K Doses)
    Table 104. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2024-2029)
    Table 105. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2024-2029) & (US$ Million)
    Table 106. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2024-2029)
    Table 107. Merck & Co. Company Information
    Table 108. Merck & Co. Introduction and Business Overview
    Table 109. Merck & Co. Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2023)
    Table 110. Merck & Co. Chickenpox (Varicella) Vaccine Product
    Table 111. Merck & Co. Recent Development
    Table 112. Sanofi Pasteur Company Information
    Table 113. Sanofi Pasteur Introduction and Business Overview
    Table 114. Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2023)
    Table 115. Sanofi Pasteur Chickenpox (Varicella) Vaccine Product
    Table 116. Sanofi Pasteur Recent Development
    Table 117. GSK Company Information
    Table 118. GSK Introduction and Business Overview
    Table 119. GSK Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2023)
    Table 120. GSK Chickenpox (Varicella) Vaccine Product
    Table 121. GSK Recent Development
    Table 122. Shanghai Institute Company Information
    Table 123. Shanghai Institute Introduction and Business Overview
    Table 124. Shanghai Institute Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2023)
    Table 125. Shanghai Institute Chickenpox (Varicella) Vaccine Product
    Table 126. Shanghai Institute Recent Development
    Table 127. BCHT Company Information
    Table 128. BCHT Introduction and Business Overview
    Table 129. BCHT Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2023)
    Table 130. BCHT Chickenpox (Varicella) Vaccine Product
    Table 131. BCHT Recent Development
    Table 132. Changsheng Company Information
    Table 133. Changsheng Introduction and Business Overview
    Table 134. Changsheng Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2023)
    Table 135. Changsheng Chickenpox (Varicella) Vaccine Product
    Table 136. Changsheng Recent Development
    Table 137. Keygen Company Information
    Table 138. Keygen Introduction and Business Overview
    Table 139. Keygen Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2023)
    Table 140. Keygen Chickenpox (Varicella) Vaccine Product
    Table 141. Keygen Recent Development
    Table 142. Green Cross Company Information
    Table 143. Green Cross Introduction and Business Overview
    Table 144. Green Cross Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2023)
    Table 145. Green Cross Chickenpox (Varicella) Vaccine Product
    Table 146. Green Cross Recent Development
    Table 147. Biken Company Information
    Table 148. Biken Introduction and Business Overview
    Table 149. Biken Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2023)
    Table 150. Biken Chickenpox (Varicella) Vaccine Product
    Table 151. Biken Recent Development
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Chickenpox (Varicella) Vaccine Market Trends
    Table 155. Chickenpox (Varicella) Vaccine Market Drivers
    Table 156. Chickenpox (Varicella) Vaccine Market Challenges
    Table 157. Chickenpox (Varicella) Vaccine Market Restraints
    Table 158. Chickenpox (Varicella) Vaccine Distributors List
    Table 159. Chickenpox (Varicella) Vaccine Downstream Customers
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Chickenpox (Varicella) Vaccine Product Picture
    Figure 2. Global Chickenpox (Varicella) Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Chickenpox (Varicella) Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Chickenpox (Varicella) Vaccine Sales Status and Outlook (2018-2029) & (K Doses)
    Figure 5. Product Picture of Monovalent Vaccine
    Figure 6. Global Monovalent Vaccine Sales YoY Growth (2018-2029) & (K Doses)
    Figure 7. Product Picture of Combination Vaccine
    Figure 8. Global Combination Vaccine Sales YoY Growth (2018-2029) & (K Doses)
    Figure 9. Global Chickenpox (Varicella) Vaccine Sales by Type (2018-2029) & (US$ Million)
    Figure 10. Global Chickenpox (Varicella) Vaccine Sales Market Share by Type in 2022 & 2029
    Figure 11. North America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type in 2022
    Figure 12. North America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type in 2022
    Figure 13. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type in 2022
    Figure 14. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type in 2022
    Figure 15. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type in 2022
    Figure 16. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type in 2022
    Figure 17. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type in 2022
    Figure 18. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type in 2022
    Figure 19. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type in 2022
    Figure 20. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type in 2022
    Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Chickenpox (Varicella) Vaccine Sales in 2022
    Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Chickenpox (Varicella) Vaccine Revenue in 2022
    Figure 23. Chickenpox (Varicella) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 24. Product Picture of Kids Injection
    Figure 25. Global Kids Injection Sales YoY Growth (2018-2029) & (K Doses)
    Figure 26. Product Picture of Adults Injection
    Figure 27. Global Adults Injection Sales YoY Growth (2018-2029) & (K Doses)
    Figure 28. Global Chickenpox (Varicella) Vaccine Sales by Application (2018-2029) & (US$ Million)
    Figure 29. Global Chickenpox (Varicella) Vaccine Sales Market Share by Application in 2022 & 2029
    Figure 30. North America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application in 2022
    Figure 31. North America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application in 2022
    Figure 32. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application in 2022
    Figure 33. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application in 2022
    Figure 34. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application in 2022
    Figure 35. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application in 2022
    Figure 36. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application in 2022
    Figure 37. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application in 2022
    Figure 38. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application in 2022
    Figure 39. Key Raw Materials Price
    Figure 40. Chickenpox (Varicella) Vaccine Manufacturing Cost Structure
    Figure 41. Chickenpox (Varicella) Vaccine Industrial Chain Analysis
    Figure 42. Channels of Distribution
    Figure 43. Distributors Profiles
    Figure 44. Bottom-up and Top-down Approaches for This Report
    Figure 45. Data Triangulation
    Figure 46. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions